Jump to page content

Translation-Hub Multi-Omics

The Multi-Omics hub aims to make omics technologies usable for translational applications. These include the establishment of standardized pipelines for the preparation of samples and data, the development of computer-aided approaches for the integration, analysis and modelling of omics data, the continuous development of omics methods and technologies, as well as omics-based diagnostic analysis and therapeutic approaches.

The hub combines modern high-throughput technologies with bioinformatic methodology for the comprehensive analysis of genes, proteins and metabolic products as well as their interactions and phenotypical characteristics. The focus here is on the analysis of clinical samples using state-of-the-art omics technologies, which not only contribute to a better understanding of pathological mechanisms, but can also be used for the diagnosis and treatment of individual patients. In cooperation with the Clinical Translation hub, omics data can be correlated with external characteristics and clinical parameters, allowing a systems-medical understanding of disease-related mechanisms as well as the diagnostic and therapeutic options.

Teaser Call

BIH Multi-Omics Lecture Series

  • BIH Multi-Omics Lecture Series

    The BIH Multi-Omics Lecture Series features discussions with leading international scientists in the fields of Bioinformatics, Genomics, Proteomics, and Metabolomics.

    Read more
Steering Committee Translation Hub Multi Omics
Prof. Dr. Nina Babel BIH, BeCAT
Prof. Dr. David Capper Charité
Dr. Naveed Ishaque BIH
Dr. Jan Philipp Junker MDC-BIMSB
Dr. Jennifer Kirwan (spokesperson) BIH, MDC
Prof. Dr. Marcus Mall BIH, Charité
Dr. Philipp Mertins (spokesperson) BIH, MDC


  • PD Dr. Mareen Matz

    Project Manager National Strategy for Gene and Cell Based Therapies, Scienctific Coordinator

    Contact information
  • Dr. Doris Meder

    Head of Strategic Science Management

    Contact information
    Phone:+49 30 450 543 045